Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1971 Jul;4(1):20–22. doi: 10.1128/iai.4.1.20-22.1971

Complement-Fixing Antigens in Burkitt Lymphoma Cell Lines

Kenneth J McCormick 1,2, Wayne A Stenback 1,2, David M Mumford 1,2, John J Trentin 1,2
PMCID: PMC416257  PMID: 4949480

Abstract

The complement-fixing (CF) activity of antigens from cultured Burkitt lymphoma cells was determined by using normal American sera as the source of antibody. Approximately 75% of the sera fixed complement with the positive cell lines. These lines contained the herpes-like virus detectable by electron microscopy. The content of CF antigen depended on the cell line used but appeared to be independent of the number of cells which produced Henle's immunofluorescence (IF) antigen. Only sera that reacted in the IF test also contained CF antibodies to the crude cell extracts.

Full text

PDF
20

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong D., Henle G., Henle W. Complement-fixation tests with cell lines derived from Burkitt's lymphoma and acute leukemias. J Bacteriol. 1966 Mar;91(3):1257–1262. doi: 10.1128/jb.91.3.1257-1262.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gerber P., Birch S. M. Complement-fixing antibodies in sera of human and nonhuman primates to viral antigens derived from Burkitt's lymphoma cells. Proc Natl Acad Sci U S A. 1967 Aug;58(2):478–484. doi: 10.1073/pnas.58.2.478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gerber P., Deal D. R. Epstein-Barr virus-induced viral and soluble complement-fixing antigens in Burkitt lymphoma cell cultures. Proc Soc Exp Biol Med. 1970 Jul;134(3):748–751. doi: 10.3181/00379727-134-34875. [DOI] [PubMed] [Google Scholar]
  4. HUEBNER R. J., ROWE W. P., TURNER H. C., LANE W. T. SPECIFIC ADENOVIRUS COMPLEMENT-FIXING ANTIGENS IN VIRUS-FREE HAMSTER AND RAT TUMORS. Proc Natl Acad Sci U S A. 1963 Aug;50:379–389. doi: 10.1073/pnas.50.2.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Henle G., Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol. 1966 Mar;91(3):1248–1256. doi: 10.1128/jb.91.3.1248-1256.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hinuma Y., Konn M., Yamaguchi J., Wudarski D. J., Blakeslee J. R., Jr, Grace J. T., Jr Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J Virol. 1967 Oct;1(5):1045–1051. doi: 10.1128/jvi.1.5.1045-1051.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Klein G., Clifford P., Klein E., Smith R. T., Minowada J., Kourilsky F. M., Burchenal J. H. Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimens and tissue cultures. J Natl Cancer Inst. 1967 Nov;39(5):1027–1044. [PubMed] [Google Scholar]
  8. Klein G., Pearson G., Nadkarni J. S., Nadkarni J. J., Klein E., Henle G., Henle W., Clifford P. Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus. J Exp Med. 1968 Nov 1;128(5):1011–1020. doi: 10.1084/jem.128.5.1011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. McCormick K. J., Stenback W. A., Trentin J. J., Klein G., Nadkarni J. S., Nadkarni J. J., Clifford P. Complement-fixation test for detection of herpes-like viruses in cell cultures of Burkitt's lymphoma. J Virol. 1969 May;3(5):525–527. doi: 10.1128/jvi.3.5.525-527.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. McCormick K. J., Van Hoosier G. L., Jr Attempts to find human adenovirus type-12 tumor antigens in human tumors. J Natl Cancer Inst. 1968 Feb;40(2):255–261. [PubMed] [Google Scholar]
  11. Nadkarni J. S., Nadkarni J. J., Clifford P., Manolov G., Fenyö E. M., Klein E. Characteristics of new cell lines derived from Burkitt lymphomas. Cancer. 1969 Jan;23(1):64–79. doi: 10.1002/1097-0142(196901)23:1<64::aid-cncr2820230107>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  12. Old L. J., Boyse E. A., Oettgen H. F., Harven E. D., Geering G., Williamson B., Clifford P. Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells. Proc Natl Acad Sci U S A. 1966 Dec;56(6):1699–1704. doi: 10.1073/pnas.56.6.1699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Pope J. H., Horne M. K., Wetters E. J. Significance of a complement-fixing antigen associated with herpes-like virus and detected in the Raji cell line. Nature. 1969 Apr 12;222(5189):186–187. doi: 10.1038/222186a0. [DOI] [PubMed] [Google Scholar]
  14. SEVER J. L. Application of a microtechnique to viral serological investigations. J Immunol. 1962 Mar;88:320–329. [PubMed] [Google Scholar]
  15. Vonka V., Benyesh-Melnick M., McCombs R. M. Antibodies in human sera to soluble and viral antigens found in Burkitt lymphoma and other lymphoblastoid cell lines. J Natl Cancer Inst. 1970 Apr;44(4):865–872. [PubMed] [Google Scholar]
  16. zur Hausen H., Henle W., Hummeler K., Diehl V., Henle G. Comparative study of cultured Burkitt tumor cells by immunofluorescence, autoradiography, and electron microscopy. J Virol. 1967 Aug;1(4):830–837. doi: 10.1128/jvi.1.4.830-837.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES